from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1518/-

LFCtreatmentdescriptionclass of inhibitor

-0.537

Amikacinug/mL Amikacintranslation

0.265

Cap5-10ug/mL Capreomycintranslation

0.064

Rox10-50 ug/mL Roxithromycintranslation

-0.713

SM2-5 ug/mL Streptomycintranslation

0.677

Tet5-10 ug/mL Tetracyclinetranslation

-0.192

Rif0.2-5ug/mL Rifampicintranscription

-0.572

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.195

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.127

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.368

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.748

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.377

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.677

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.972

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.883

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.640

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.503

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.116

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.129

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.311

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.064

KCN5-20 ug/mL Potassium cyaniderespiration

0.490

NaN30.2-2 mM Sodium aziderespiration

-0.849

Nigericin50 uM Nigericinrespiration

0.332

TRC10-150 ug/mL Triclosanrespiration

0.724

TRZ10-25 ug/mL Thioridazinerespiration

-0.472

Valinomycin0.5-10 uM Valinomycinrespiration

3.033

ZnSO42 mM ZnSO4respiration

0.367

menadione6-10 ug/mL Menadionerespiration

0.123

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.596

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.362

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.005

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.528

NRP_1Non-replicating persistence stage 1dosRassociated

-0.285

Amp0.2mg/mL AmpicillincellWall

-0.138

Cephalexin20-100 ug/mL CephalexincellWall

1.546

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.650

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.381

EMB10-20 ug/mL EthambutolcellWall

1.190

Eta12-40 ug/mL EthionamidecellWall

0.848

INH0.2-0.4 ug/mL IsoniazidcellWall

1.350

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.089

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.815

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.924

BZA0.12 mg/mL BenzamidearomaticAmides

-0.544

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.228

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.383

H2O24 mM hydrogen peroxideDNAdamaging

-0.251

Levo10 ug/mL LevofloxacinDNAdamaging

-0.196

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.167

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.575

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.298

UVUV-irradiationDNAdamaging

0.527

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.106

Antimycin12.5-50 ug/mL Antimycin A?

-0.738

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.178

PA_110-50 ug/mL Antitubercular compound PA-1?

0.136

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.549

PA8240.2-2 ug/mL PA-824?

-0.090

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.267

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.812

Verapamil50 uM Verapamil?

-0.366

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.835

methoxatin10-20 ug/mL Methoxatin?